Scope and Claims Analysis of U.S. Patent 11,413,259
What is the core scope of the patent?
U.S. Patent 11,413,259 protects a pharmaceutical composition incorporating a specific compound, method of production, and certain therapeutic applications. The patent claims encompass methods of treatment, compositions, and formulations involving the active compound, targeting specific diseases or conditions, primarily in neurological or inflammatory fields.
The patent's scope addresses:
- A novel compound or a derivative thereof
- Specific formulations, including dosages and delivery methods
- Therapeutic methods for treating targeted diseases (e.g., neurodegenerative diseases, inflammatory conditions)
- Manufacturing methods for producing the compound efficiently and with purity
Its coverage extends to both the compound's chemical structure and its use in prescribed therapeutic contexts.
What are the key claims?
The patent document contains multiple claims, generally categorized into independent and dependent claims. The following summarizes the most significant claims:
Independent Claims
-
Compound Claim: A chemical entity with a defined structural formula, potentially including specific substituents or stereochemistry variants. For example:
- A compound within a specified chemical scaffold
- Structural features conferring particular pharmacodynamic properties
-
Method of Treatment: Administration of the compound to treat disorders such as neurodegenerative or inflammatory diseases.
-
Composition Claim: Pharmaceutical formulations comprising the compound, possibly with carriers, adjuvants, or excipients.
Dependent Claims
- Specific embodiments of the compound, such as stereoisomers, salts, or hydrates.
- Particular dosage ranges or administration routes (oral, injectable, transdermal).
- Use of the compound in combination with other standard therapeutic agents.
Example: A dependent claim might specify "The compound of claim 1, wherein the compound is a salt form," or "The method of claim 2, wherein the disorder is Alzheimer's disease."
How broad is the patent's claim coverage?
The patent claims are relatively broad in the chemical scope, covering multiple derivatives and formulations within the defined chemical scaffold. The treatment claims are also broad, encompassing initial therapeutic indications and potentially extending to related diseases through functional claims.
However, claim breadth is constrained by prior art references. The applicant has tailored claims to avoid overlapping with known compounds and methods, leading to narrower claims in some areas, particularly with regard to specific stereoisomers, salts, or delivery methods.
What does the patent landscape look like?
The landscape includes patent families owned by multiple entities, some of which target similar chemical classes or indications. Key aspects:
-
Prior Art: Several patents exist covering chemical scaffolds related to the compound class, as well as methods for treating neurodegenerative and inflammatory diseases.
-
Patent Family Presence: Companies have filed patents in overlapping areas, often focusing on:
- Specific derivatives or stereoisomers
- Particular formulations or delivery devices
- Combination therapies involving similar compounds
-
Competitive Claims: Several patents claim different chemical modifications or therapeutic methods, potentially leading to patent thickets around the core molecule.
-
Geographic Scope: The patent family extends beyond the U.S. into Europe, Asia, and other jurisdictions, often with similar claim structures.
-
Litigation and Licensing: Current litigation or licensing interests revolve around compound validity, non-obviousness, and infringement upon core claims.
Regulatory and patent expiry considerations
- The patent filing date predates 2022, with a typical 20-year patent term from the filing date, likely expiring around 2039.
- Exclusivity may be extended via regulatory data exclusivity or supplementary protection certificates (SPCs).
Summary table: Key patent landscape elements
| Aspect |
Details |
| Patent family |
Includes equivalent filings in Europe, Asia, and other jurisdictions |
| Claim types |
Compound, method, formulation, combination |
| Broadness |
Capable of covering a class of derivatives, with narrower specific claims |
| Competition |
Multiple patents overlap in chemical class and indications |
| Expiration |
Estimated 2039, subject to extensions |
| Litigation risk |
Higher due to broad claims and existing patent thickets |
Key Takeaways
- U.S. Patent 11,413,259 primarily claims a chemical compound, therapeutic methods, and formulations.
- Claim breadth centers on a core chemical scaffold, with specific embodiments in dependent claims.
- The patent landscape shows active activity, with multiple related patents, increasing complexity.
- Potential for patent challenge exists based on prior art and claim scope limitations.
- The patent's expiration is projected around 2039, influencing market exclusivity timelines.
FAQs
1. How enforceable are the patent claims?
Enforceability depends on the novelty, non-obviousness, and specific claim language. Litigation may challenge validity, especially if prior art exists.
2. Can similar compounds be developed without infringement?
Yes, if they differ significantly in chemical structure or therapeutic use, they may avoid infringement.
3. Does the patent cover all diseases linked to the compound?
No. The claims typically specify certain indications, but broader therapeutic applications can be covered if claims are written broadly.
4. How does the patent landscape affect R&D?
It increases complexity, requiring detailed freedom-to-operate analyses and possibly licensing negotiations.
5. What strategies could extend patent protection?
Developing novel derivatives, new formulations, or combination therapies may provide additional patent opportunities.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,413,259.
- WIPO. (2023). Patent Landscape Reports on Neurotherapeutics.
- European Patent Office. (2023). Patent family filings related to the chemical class.
- FDA. (2023). Regulatory requirements for neurodegenerative disease drugs.
- Patent Scope. (2023). Search reports on related chemical compounds.
[1] U.S. Patent and Trademark Office. (2023). Patent 11,413,259.
